Chinese inhibitor drug candidate becomes first to enter phase
Release time：2024-05-09 04:16:52 Source：Stellar Stories news portal
Chinese biotech company Jacobio Pharma announced on Monday that it had received approval from Chinese regulatory authorities for the registration phase-3 clinical trial of a combination therapy using its SHP2 inhibitor drug candidate JAB-3312.
SHP2 inhibitors are expected worldwide to have a substantial clinical effect in cancer and immunity disease treatment, and the approval made JAB-3312 the first SHP2 inhibitor to enter the phase-3 clinical study globally.
The approved clinical study in China is designed to evaluate the efficacy and safety of JAB-3312 in combination with the company's other investigational drug candidate KRAS G12C inhibitor glecirasib, for treating first-line non-small cell lung cancer patients with KRAS G12C mutations.
The control arm is the current standard treatment for first-line non-small cell lung cancer, which is the combination therapy of PD-1 antibody and chemotherapy.
- Previous：A Cambodian court sentences a union leader to 18 months in prison for comments on Facebook
- Next：Head and Sharma's electrifying opening stand earns Hyderabad 10
Related articles
- Neighbour, 33, admits killing girl, 11, with poisonous gas used to kill bed bugs
- China Steadily Improves People's Wellbeing over Past 5 Years: Report
- Innovative Tea
- Various Folk Cultural Activities Held to Celebrate Lantern Festival in China
- Trial begins for ex
- China Names Demonstration Cities for Childcare Services
- Tea Industry Cultivated to Boost Local Farmers' Income in SW China
- Asia's Leading Flower Market Cashes in on 'She Economy'
- High school students, frustrated by lack of climate education, press for change
- Farmers in Hangzhou Start Harvesting Longjing Tea Leaves Ahead of Qingming Festival
- Prada focuses generational transition on artisans, expanding production and workforce in Italy
- China Issues Dietary Handbook for Kids with Growth Failure
- Chinese Aviation History Museum Takes off in Beijing
- Boarding Schools Ensure Fairer Education in Tibet
- Chinese leader Xi Jinping set to meet Serbian officials on the second leg of his Europe tour
- Yuntai Mountain Hanfu Huazhao Festival Kicks off in C China's Henan
- Grocery Store in Rural China Now Community E
- Spring Ploughing and Seedling Raising Start in SW China's Guizhou
- Kai Cenat's riot charges dropped after he apologizes and pays for Union Square mayhem
- A vocation with character
Random recommendation
- Copyright © 2024 Powered by Chinese inhibitor drug candidate becomes first to enter phase ,Stellar Stories news portal sitemap